Photodynamic Therapy
Omnilux™ was originally developed at the Paterson Institute for Cancer Research. Its optimized intensity and adjustable dose function have been used in the treatment of thousands of non-melanoma lesions. It is especially effective in cosmetically sensitive areas and for lesions in poor healing sites. Compared with conventional modalities, treatment outcomes are excellent, with significantly fewer adverse events.[1]
Specifically, the use of Omnilux along with ALA-PDT has been shown to be optimally effective in treating:
- Non-hyperkeratotic actinic keratoses (AKs) on the face, chest, and scalp.
- Bowen’s disease
- Superficial Basal cell carcinomas (sBCCs) (less than 2 mm thick).
References
![Screen Shot 2021-10-18 at 10.59.21 pm](http://omniluxaustralia.com.au/wp-content/uploads/2021/10/Screen-Shot-2021-10-18-at-10.59.21-pm.png)
Omnilux PDT is specially effective in cosmetically sensitive areas.
![photodynamic-therapy_before_after_left-popup](http://omniluxaustralia.com.au/wp-content/uploads/2021/10/photodynamic-therapy_before_after_left-popup.png)
![photodynamic-therapy_before_after_right-popup](http://omniluxaustralia.com.au/wp-content/uploads/2021/10/photodynamic-therapy_before_after_right-popup.png)
Speak to us today